BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35668420)

  • 21. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research.
    Carey DJ; Fetterolf SN; Davis FD; Faucett WA; Kirchner HL; Mirshahi U; Murray MF; Smelser DT; Gerhard GS; Ledbetter DH
    Genet Med; 2016 Sep; 18(9):906-13. PubMed ID: 26866580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses.
    Wain KE; Tolwinski K; Palen E; Heidlebaugh AR; Holdren K; Walsh LK; Oetjens MT; Ledbetter DH; Martin CL
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34062946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.
    Kullo IJ; Olson J; Fan X; Jose M; Safarova M; Radecki Breitkopf C; Winkler E; Kochan DC; Snipes S; Pacyna JE; Carney M; Chute CG; Gupta J; Jose S; Venner E; Murugan M; Jiang Y; Zordok M; Farwati M; Philogene M; Smith E; Shaibi GQ; Caraballo P; Freimuth R; Lindor NM; Sharp R; Thibodeau SN
    Mayo Clin Proc; 2018 Nov; 93(11):1600-1610. PubMed ID: 30392543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
    van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
    Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Germline gene testing of the RET, VHL, SDHD and SDHB genes in patients with pheochromocytoma/paraganglioma].
    Wu K; Zhang Y; Zhang H; Tan ZH; Guo XH; Yang JM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):634-639. PubMed ID: 30122763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
    Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.
    Horton C; LaDuca H; Deckman A; Durda K; Jackson M; Richardson ME; Tian Y; Yussuf A; Jasperson K; Else T
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1917-e1923. PubMed ID: 35026032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.
    Carruth ED; Beer D; Alsaid A; Schwartz MLB; McMinn M; Kelly MA; Buchanan AH; Nevius CD; Calkins H; James CA; Murray B; Tichnell C; Matsumura ME; Kirchner HL; Fornwalt BK; Sturm AC; Haggerty CM
    Circ Genom Precis Med; 2021 Apr; 14(2):e003302. PubMed ID: 33684294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.
    Bennedbæk M; Rossing M; Rasmussen ÅK; Gerdes AM; Skytte AB; Jensen UB; Nielsen FC; Hansen TVO
    Hered Cancer Clin Pract; 2016; 14():13. PubMed ID: 27279923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
    Jiménez C; Cote G; Arnold A; Gagel RF
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2851-8. PubMed ID: 16735498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Family With a Carotid Body Paraganglioma and Thyroid Neoplasias With a New
    Wolf KI; Jacobs MF; Mehra R; Begani P; Davenport MS; Marentette LJ; Basura GJ; Hughes DT; Else T
    J Endocr Soc; 2019 Nov; 3(11):2151-2157. PubMed ID: 31687641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of hereditary head and neck paragangliomas.
    Boedeker CC; Hensen EF; Neumann HP; Maier W; van Nederveen FH; Suárez C; Kunst HP; Rodrigo JP; Takes RP; Pellitteri PK; Rinaldo A; Ferlito A
    Head Neck; 2014 Jun; 36(6):907-16. PubMed ID: 23913591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative.
    Baker A; Tolwinski K; Atondo J; Davis FD; Goehringer J; Jones LK; Pisieczko CJ; Sturm AC; Williams JL; Williams MS; Rahm AK; Buchanan AH
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical and psychosocial outcomes of state-funded population genomic screening.
    Cannon A; McMillan O; Kelley WV; East KM; Cochran ME; Miskell EL; Moss IP; Garner-Duckworth S; Redden DT; Might M; Barsh GS; Korf BR
    Clin Genet; 2023 Oct; 104(4):434-442. PubMed ID: 37340305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A registry-based study of thyroid paraganglioma: histological and genetic characteristics.
    von Dobschuetz E; Leijon H; Schalin-Jäntti C; Schiavi F; Brauckhoff M; Peczkowska M; Spiazzi G; Demattè S; Cecchini ME; Sartorato P; Krajewska J; Hasse-Lazar K; Roszkowska-Purska K; Taschin E; Malinoc A; Akslen LA; Arola J; Lange D; Fassina A; Pennelli G; Barbareschi M; Luettges J; Prejbisz A; Januszewicz A; Strate T; Bausch B; Castinetti F; Jarzab B; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2015 Apr; 22(2):191-204. PubMed ID: 25595276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours.
    De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI
    Eur J Endocrinol; 2017 May; 176(5):635-644. PubMed ID: 28220018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.